Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > MYCO is the Only TRUE Competitor to CMPS 🚀

<< Previous

Bullboard Posts

Next >>

Comment by knowsbeston Nov 30, 2020 12:37pm

182 Views

Post# 32001084

RE:MYCO is the Only TRUE Competitor to CMPS 🚀

Agree very stongly . A better strategy .A better management . Much more vertically integrated .

Not to mention the APP and the London listing . The only thing I amd afraid of is they will be taken out much too soon .

<< Previous

Bullboard Posts

Next >>

Nintendo stock hits new all-time high as excitement builds over Switch successor